Abstract
Human herpesvirus 6B (HHV-6B) is a ubiquitous pathogen that infects most individuals before the age of three years. HHV-6B reactivates in approximately 40% of transplant recipients where it has been associated with a number of important outcomes, especially in allogeneic transplant recipients. This article will review the epidemiology, clinical manifestations, diagnosis, and treatment of HHV-6B infection.
MeSH terms
-
Antiviral Agents / therapeutic use
-
Encephalitis, Viral / diagnosis*
-
Encephalitis, Viral / drug therapy*
-
Encephalitis, Viral / epidemiology
-
Encephalitis, Viral / virology
-
Foscarnet / therapeutic use
-
Ganciclovir / therapeutic use
-
Herpesvirus 6, Human* / physiology
-
Humans
-
Roseolovirus Infections / diagnosis*
-
Roseolovirus Infections / drug therapy*
-
Roseolovirus Infections / epidemiology
-
Transplant Recipients*
-
Virus Activation
Substances
-
Antiviral Agents
-
Foscarnet
-
Ganciclovir